Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B

Background and AimCessation of nucleos(t)ide analogs (NAs) therapy in patients with chronic hepatitis B (CHB) is uncommon. Although criteria for discontinuation appear in some guidelines, the indicators for assessing discontinuation of NAs are limited, whether NAs can be safely ceased remains a diff...

Full description

Bibliographic Details
Main Authors: Fa-Da Wang, Jing Zhou, Lan-Qing Li, Meng-Lan Wang, Ya-Cao Tao, Yong-Hong Wang, Dong-Mei Zhang, En-Qiang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Microbiology
Subjects:
chronic hepatitis B
discontinuation
hepatitis B core-associated antigen
nucleos(t)ide analogs
pregenomic RNA
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.901233/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.901233/full

Similar Items